These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19822230)

  • 1. The smallpox vaccine induces an early neutralizing IgM response.
    Moyron-Quiroz JE; McCausland MM; Kageyama R; Sette A; Crotty S
    Vaccine; 2009 Dec; 28(1):140-7. PubMed ID: 19822230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological responses in humans to the smallpox vaccine LC16m8.
    Johnson BF; Kanatani Y; Fujii T; Saito T; Yokote H; Smith GL
    J Gen Virol; 2011 Oct; 92(Pt 10):2405-2410. PubMed ID: 21715598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.
    Benhnia MR; McCausland MM; Su HP; Singh K; Hoffmann J; Davies DH; Felgner PL; Head S; Sette A; Garboczi DN; Crotty S
    J Virol; 2008 Apr; 82(7):3751-68. PubMed ID: 18234801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
    Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
    J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
    Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
    Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
    Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM
    J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation?
    Mariotti S; Venturi G; Chiantore MV; Teloni R; De Santis R; Amendola A; Fortuna C; Marsili G; Grilli G; Lia MS; Kiros ST; Lagi F; Bartoloni A; Iacobino A; Cresta R; Lastilla M; Biselli R; Di Bonito P; Lista F; Nisini R
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of monkeypox- and vaccinia-virus neutralizing antibodies before and after smallpox vaccination: A sero-epidemiological study.
    Marchi S; Piccini G; Cantaloni P; Guerrini N; Zannella R; Coluccio R; Benincasa L; Solfanelli N; Remarque EJ; Viviani S; Kistner O; Temperton N; Montomoli E; Manenti A; Trombetta CM
    J Med Virol; 2024 Jun; 96(6):e29728. PubMed ID: 38860589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.
    Benhnia MR; Maybeno M; Blum D; Aguilar-Sino R; Matho M; Meng X; Head S; Felgner PL; Zajonc DM; Koriazova L; Kato S; Burton DR; Xiang Y; Crowe JE; Peters B; Crotty S
    J Virol; 2013 Feb; 87(3):1569-85. PubMed ID: 23152530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capturing the natural diversity of the human antibody response against vaccinia virus.
    Lantto J; Haahr Hansen M; Rasmussen SK; Steinaa L; Poulsen TR; Duggan J; Dennis M; Naylor I; Easterbrook L; Bregenholt S; Haurum J; Jensen A
    J Virol; 2011 Feb; 85(4):1820-33. PubMed ID: 21147924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
    Viner KM; Isaacs SN
    Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis.
    Eto A; Fujita M; Nishiyama Y; Saito T; Molina DM; Morikawa S; Saijo M; Shinmura Y; Kanatani Y
    Vaccine; 2019 Oct; 37(44):6588-6593. PubMed ID: 31540810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smallpox vaccination campaigns resulted in age-associated population cross-immunity against monkeypox virus.
    Dee K; Manali M; Bissett LA; Bone J; Magill C; Davis C; Willett BJ; Murcia PR
    J Gen Virol; 2024 Jun; 105(6):. PubMed ID: 38861287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
    Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
    PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.
    Meseda CA; Mayer AE; Kumar A; Garcia AD; Campbell J; Listrani P; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Clin Vaccine Immunol; 2009 Sep; 16(9):1261-71. PubMed ID: 19605597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
    Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
    Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination.
    Pütz MM; Midgley CM; Law M; Smith GL
    Nat Med; 2006 Nov; 12(11):1310-5. PubMed ID: 17086190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.
    García AD; Meseda CA; Mayer AE; Kumar A; Merchlinsky M; Weir JP
    Clin Vaccine Immunol; 2007 Aug; 14(8):1032-44. PubMed ID: 17596428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.